Blog

  • Kerala offer investment prospects for the UAE, with healthcare on the list

    Kerala offer investment prospects for the UAE, with healthcare on the list

    In a sign of strengthening ties between India and the United Arab Emirates (UAE), the West Asian country has said that it is looking for investment opportunities in key sectors such as healthcare, tourism, food processing, and technology in Kerala.

    Abdulla bin Touq Al Marri, UAE minister of economy, said on Saturday that the economic partnership between the two nations has witnessed remarkable growth over the years. He was in Kerala to attend the Invest Kerala Global Summit (IKGS).

    “The UAE is actively exploring investment opportunities across key sectors such as healthcare, tourism, food processing, and technology. With a vision for sustainable growth, our investments are not only shaping economic progress but also addressing global challenges— enhancing healthcare access, strengthening food security, driving technological innovation, and fostering resilient economies worldwide,” Marri, who was leading a 22-member delegation at the event, told the media.

    On Saturday, UAE-based shipping and logistics major Sharaf Group announced that it will invest Rs 5,000 crore in Kerala.

    Interestingly, in a tribute to the UAE’s 2025 theme, the ‘Year of Community,’ the North Malabar Chamber of Commerce hosted the ‘Year of Community Run’ on Sunday to strengthen ties between the two countries. It was organised as part of the 8th edition of the Kannur Beach Run, celebrating the message of inclusivity, well-being, and global togetherness.

    Marri participated in the 5-kilometer run alongside Shamsheer Vayalil, chairman and managing director of UAE-based VPS Healthcare, and over 100 participants.

    “We are honoured to have the minister join us for this special event. His presence has elevated the theme and spirit of the ‘Year of Community Run.’ We hope such initiatives will continue to strengthen community-driven efforts between both countries and inspire greater awareness around sports, wellness, and social engagement,” said the organisers.

    The Kannur Beach Run 2025, organised by the North Malabar Chamber of Commerce, lived up to its reputation as one of Kerala’s premier running events, drawing over 1,000 participants across multiple race categories.

    The event also saw the participation of six elite Ethiopian runners. Business Standard

  • Hope Health Care and Diagnostic Lab launched in Nagaland’s Chümoukedima 

    Hope Health Care and Diagnostic Lab launched in Nagaland’s Chümoukedima 

    Hope Health Care and Diagnostic Lab, launched by Finding Hope, India in partnership with Finding Hope Global, was officially inaugurated by Mhathung Yanthan, MLA and Advisor to the Department of Agriculture, at the Multipurpose Educational Centre in Naga United Village, Chümoukedima on February 22.

    The new Health Care Diagnostic Lab, a collaboration between Finding Hope India and Finding Hope Global, aims to serve the underserved and marginalized communities by offering up to a 60% discount on diagnostic tests.

    In his address, Advisor Mhathung Yanthan expressed his gratitude to Finding Hope Global and Yanren Kikon for bringing such a meaningful initiative to Nagaland. He marked the event as the beginning of a new era of service, healing, and transformation. He also highlighted the Chief Minister’s Health Insurance Scheme and the Ayushman Health Scheme as vital components of the state’s efforts to improve healthcare.

    Yanren Kikon, Director of Finding Hope, India, shared the inspiration behind the initiative. He recalled waiting anxiously for his wife’s treatment in a hospital and how it fuelled his desire to create a facility that would offer hope to others in similar situations. The lab, he hopes, will be a place of healing and transformation for the community.

    Dr Nathan Merril of Finding Hope Global also spoke about his inspiration for the initiative, which began with his wife’s desire to create a home for orphans and abandoned children. Officially launched in the USA in 2016, the organization has since expanded to Romania, Brazil and now India.

    Rev Dr Ruokuovillie Sachu, who also led the program, delivered the vote of thanks. The event concluded with a benediction by Kuhusheyi Chotso, Pastor of Naga United Village Baptist Church.

    The programme began with an opening prayer by Yanbemo Ovung, Associate Pastor of LBCD, followed by a welcome address by Abalu Kikon. A special performance was given by Thunglamo Ngullie, and the closing prayer was offered by Pastor Kuhusheyi Chotso. Morung Express

  • Apollo Hospitals eyes Indonesia, Sri Lanka, Middle East to make up for Bangladesh setback 

    Apollo Hospitals eyes Indonesia, Sri Lanka, Middle East to make up for Bangladesh setback 

    In view of the drop in patient footfall from Bangladesh due to the political turmoil that gripped the country, Apollo Hospitals Enterprise Ltd (AHEL) is looking at different overseas markets to support growth. The firm has its eyes on Indonesia, Iraq, Iran, Sri Lanka, Middle East and Africa, among others.

    According to Dr Sangita Reddy, Joint Managing Director, AHEL, tapping into these new markets is “likely to make up” or off-set the impact of lower footfalls from Bangladesh, over a three-month period or so.

    “There is Fiji… we’re focusing on Africa including Guyana of course; we’re also seeing a significant increase in other markets. Bangladesh (political turmoil) has affected us, and we hope that the situation will ease out. And those numbers will come back,” she told businessline on the sidelines of the International Health Dialogue.

    “We may have a three-month lag, but we will make up (through focus on new markets),” Reddy added.

    Hospital chains in India are known to charge a premium for foreign patientsn, which vary in the 15-20 per cent-odd range. Hence, a drop in patient footfall from Bangladesh, one of the largest markets, has impacted earnings.

    Other countries
    The company top-brass in their earnings call said, revenue from international patients other than Bangladesh rose by 19 per cent year-on-year.

    According to Reddy, India has a large population and Apollo will continue to serve whoever needs them.

    The company has a ₹6,000-crore-odd expansion plan underway that includes an addition of nearly 3,000-odd beds (capex for each bed being in the ₹2-crore range) over a five-year period. And, nearly 50 per cent of capacity is expected to be operationalised over the next three years. Some of the key cities being tapped include Hyderabad, Chennai, Gurugram, Mumbai, Bengaluru, among others.

    Expansion mode
    With new facilities coming up, Apollo is expecting occupancy rates to be in the 72-73 per cent range over a 12-24-month period. Currently, occupancies are at 68 per cent.

    “… by then, we would have found some level of replacement for the Bangladesh revenues and volumes, in terms of other foreign markets,” the company top brass had said during the call. Most patients from Bangladesh were coming to Chennai and Tamil Nadu, which is why the impact on Chennai is an almost a 3-plus per cent.

    For the quarter ending December 31, 2024, AHEL reported a consolidated revenue or ₹5,527 crore, up by 14 per cent y-o-y, and a consolidated EBITDA stood at ₹762 crore, up 24 per cent y-o-y. The Hindu Business Line

  • India calls for global healthcare collaboration 

    India calls for global healthcare collaboration 

    External Affairs Minister S Jaishankar on Saturday emphasised the importance of global healthcare collaboration, stating that healthcare is a fundamental right, not just a privilege.

    Addressing the 12th International Health Dialogue conference, Jaishankar highlighted India’s efforts in promoting healthcare as a fundamental right, citing initiatives like the Ayushman Bharat program, which provides health insurance to millions of citizens while addressing the gathering at a session titled ‘Global Changemakers – Transformation in Patient Safety’.

    “In this day and age, health care is a fundamental right. It’s not just a privilege. The global south cannot be a hostage to uncertain supply chains and the vagaries of the global economy. The Covid period was a real learning experience for all of us,” said Jaishankar.

    Jaishankar also stressed the need for international partnerships to strengthen healthcare systems, enhance patient safety, and ensure affordable access.

    “We must be prepared for the next challenge. All of us want to strengthen healthcare systems, enhance patient safety, and ensure affordable access. These goals would be better achieved if we collaborate more closely. And to the world, therefore, my message would be of the importance of international partnerships,” said Jaishankar.

    The EAM said that a lot that India contributes is through its own progress and example, highlighting the fact that India promoted the International Day of Yoga, the Lifestyle for Environment Initiative – LIFE Initiative, and more nutritious practices, such as the consumption of millets.

    Jaishankar also gave the example of Ayushman Bharat Initiative, Aabha IDs, Jan Aushadi Kendras and the power of digital public infrastructure.

    “The Ayushman Bharat Initiative, as you would have heard from other speakers, is today the world’s largest government health insurance. About 750 million of our citizens have received Aabha IDs, and they have access to 360,000 healthcare facilities and 570,000 healthcare professionals. To do this on such a scale at our level of per capita income is actually a testimony to the power of digital public infrastructure. And that, in turn, reflects the deep commitment to good governance of the Modi government. For many citizens, the cost of medicines required for the treatment of chronic ailments is also a particular anxiety. Here, too, we have demonstrated through the 14,000 Jan Aushadi Kendras, the people’s pharmacy, that caring policies and smart inventory management can bring down the cost of medicines for a common person,” said Jaishankar.

    Furthermore, Jaishankar emphasized the importance of traditional medicine, highlighting India’s efforts to promote Ayurveda and other traditional practices.

    “As we seek to balance tradition and technology as the twin forces of national progress, it is also natural that we will explore the relevance of our own heritage and culture to the health of our people, and by the way, encourage other societies in a similar position to do so. Especially during the Covid period, there was a sharper realization of the utility and efficacy of traditional medicine to preventive healthcare recovery and wellness. India has the privilege to host the WHO Global Centre of Traditional Medicine in Gujarat. As a government which created a department called AYUSH to promote these very practices and treatments,” said Jaishankar.

    He noted that India has been actively promoting medical value travel through the “Heal In India” initiative, making it easier for foreign patients to receive treatment in India.

    “Through the ‘Heal In India’ initiative, our government is committed to promoting medical value, travel, and making it easier for foreign patients to obtain treatment in India,” said Jaishankar.

    Emphasising the importance of medical partnership in both the global south and north, the External Affairs Minister said there was an acute shortage of doctors, nurses, and health workers in the global north as well, including North America, Europe, and Japan.

    “It’s not just the global south which requires a stronger medical partnership, so does the global north. There is an acute shortage of doctors, nurses, and health workers in a very large number of countries in the global north, in North America, Europe, Japan, and the Far East. When we negotiate mobility partnerships today, one driver of this is actually to help them address their growing health needs, which obviously has to take into account an ageing population,” he said.

    Jaishankar also mentioned India’s contribution to global healthcare, including the dispatch of medical supplies to countries in need and the training of medical professionals in Africa.

    “Recently, we dispatched 66.5 tons of medical supplies to deal with the humanitarian crisis in Gaza. A little before that, a consignment of 1400 kg of anti-cancer medicines was sent to strengthen the medical capabilities of hospitals in Syria. Even in Afghanistan, India has stepped forward with 300 tons of medicines in the last few years, as well as the dispatch of specialists to a hospital that we had built in Kabul,” he added.

    The EAM further underscored the importance of Covid experience which was a reminder to many nations to develop national capacities in this crucial domain. He gave example of e-Arogya Bharti initiative where the Indian companies, as well as the Indian government sought to localize production and strengthen capabilities.

    “One of our significant efforts in this direction has been the e-Arogya Bharti initiative to train medical students and paramedics in Africa through online classes. By diversifying the production of medicines and expanding the scale of medical professionals, we are strengthening the ability of the Global South to address its core concerns,” said Jaishankar.

    In fact, India’s digital health initiatives, such as the Ayushman Bharat Digital Mission, have shown promising results in improving healthcare access and outcomes. The country’s experience in leveraging technology to strengthen healthcare systems could serve as a valuable lesson for other nations.

    “India today has delivered more than 600 significant development projects in 78 nations across the world. Now, many of them are in the health sector. In parallel, the private health industry of India has also contributed to facilities and capacities in different geographies and I want to say today that we value this industry as a partner. From speciality hospitals to primary health centres, we have sought to make a difference across a wide spectrum,” added Jaishankar.

    Jaishankar’s call for global healthcare collaboration comes at a time when the world is facing numerous health challenges. As India continues to play a significant role in promoting global healthcare, Jaishankar’s emphasis on international partnerships and collaboration is a timely reminder of the need for collective action to address the world’s health challenges.

    “A large number of developing nations received made in-India vaccine (Covid) either through our ‘Vaccine Maitri’ initiative, or other global programs. Now, this was in contrast to many developed countries that had stockpiled vaccines to the multiples of their population. Indian medical teams also went out in the Indian Ocean region to deal with pressing situations in some smaller countries. But this was not just an exception made during the Covid era. In fact, it is part of our approach to the world both before and after,” said Jaishankar. ANI

  • Boston Scientific announces pricing of senior notes

    Boston Scientific Corporation announced that American Medical Systems Europe B.V. (“AMS Europe”), its wholly owned finance subsidiary, has priced a public offering of €850,000,000 aggregate principal amount of 3.000% notes due 2031 and €650,000,000 aggregate principal amount of 3.250% notes due 2034 (collectively, the “Notes”). The Notes will be fully and unconditionally guaranteed by the Company. The offering is being made pursuant to a registration statement filed with the U.S. Securities and Exchange Commission.

    The offering is expected to close on February 26, 2025, subject to customary closing conditions. The Company intends to use the net proceeds from the offering, together with cash on hand, to fund the repayment at maturity of AMS Europe’s 0.750% senior notes due March 8, 2025 and to pay accrued and unpaid interest with respect to such notes, and for general corporate purposes, which may include, among other things, short term investments, reduction of short term debt, funding of working capital and potential future acquisitions.
    NewsBit Bureau

  • Vascular access devices market to reach USD 9.05 bn

    Vascular access devices market to reach USD 9.05 bn

    The global vascular access devices market, valued at USD 5.60 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching USD 5.99 billion in 2024 and an impressive USD 9.05 billion by 2030. The increasing prevalence of chronic diseases, such as cancer and chronic kidney diseases, drives market growth. Additionally, increased government support for the construction of healthcare infrastructure and technological advancements are expected to impact market growth. The increasing number of hospitals globally also poses an opportunistic factor for market growth.

    Based on type, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous vascular access device, and accessories. Among these, in 2023, the central venous access device segment accounted for the highest market share in the vascular access device market. This is owing to increasing incidence of cancer cases and chronic diseases such as chronic kidney diseases. Additionally, increasing chemotherapy procedure fuels the market growth for vascular access devices. Central venous access devices are further divided into peripherally inserted central catheters, tunnelled catheters, non-tunnelled catheters, and implantable ports. Among these, the peripherally inserted central catheter to hold the largest market share in 2023. As peripherally inserted central catheters are less likely to pose any complications after the insertion of the device, thus majority of the times in developed regions these devices are preferred over other central venous access devices. As the prevalence of chronic diseases increases the need of central line is rising for long-term therapy, thus increasing the demand for central venous access devices across the globe. Among these, tunnelled catheters to grow at the fastest rate during forecast period. This is due to increasing prevalence of chronic kidney diseases. During haemodialysis procedure these tunnelled catheters are preferred as these are associated with less complications and can be there in the body for 3 to 6 months.

    Based on route of insertion, the vascular access device market is segmented into intravenous route of insertion, subcutaneous route of insertion, and intraosseous route of insertion. Among these, the intravenous route of insertion segment accounts for the largest share of the vascular access device market in 2023. As majority of the vascular access devices such as peripherally inserted central venous catheters, tunneled catheter, non-tunneled catheters, peripheral intravenous catheter, midline catheters, winged or butterfly needles are inserted via intravenous route. As the usage of these devices is increasing due to rising prevalence of lifestyle diseases, thus contributing to the market growth. Additionally, for subcutaneous and intraosseous route of insertion the specific healthcare professionals are required for the insertion of the devices. Thus, majority of the healthcare professionals prefer the intravenous route of insertion for various applications. The subcutaneous segment to hold the second largest position, owing to increasing incidence of cancer cases across the globe.

    By region, the vascular access device market is divided into 5 main regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these regions, in 2023, the North American region holds the largest market share in the vascular access device market, owing to increasing prevalence of chronic diseases such as chronic kidney diseases, cancer, cardiovascular diseases and among others. For instance, as per National Cancer Institute, there will be 2,001,140 new cancer cases in 2024 in US. Additionally, the center for disease control and prevention stated in 2023, that more than 1 in 7 adults, (approximately 35.5 million people) are estimated to have one chronic kidney disease (CKD).

    Furthermore, they stated in February 2024 that 129 million American suffer at least one major chronic disease. As these diseases require generally long-term hospitalizations, which includes intravenous medication administration, thus driving the market growth. The North American vascular access device market is divided into US, and Canada. Among these, US holds the largest market share in 2023, owing to the presence of key manufacturing players in the region is supporting the market growth. As these companies are heavily investing for research and development thus contributing to the market growth in US. Additionally in Canada the growth of the vascular access device market is due to increasing clinical trials conducted in this region. For instance, in August 2024 the phase 3 clinical trial on intranasal fentanyl in preterm infants undergoing peripherally inserted central catheter placed got completed at Mount Sinai Hospital in Canada. As the number of clinical trials increases, the demand for these devices is also rising, supporting market growth in the region. The Asia Pacific region accounted for a significant share of the global vascular access device market in 2023 and is expected to grow at the fastest CAGR during the forecast period, driven by an increasing aging population and the rising prevalence of chronic diseases. The Asia Pacific region includes Japan, China, India, Australia, South Korea, and the rest of the region. Among these, China held the largest share of the Asia Pacific vascular access device market in 2023, attributed to the country’s rapidly aging population and the growing prevalence of chronic diseases. For instance, in 2022, there were 280.04 million people aged 60 and above, with chronic diseases affecting 66.3% of older adults, including conditions like cardiovascular diseases and cancers. This growing healthcare demand is necessitating efficient vascular access devices for long-term therapies further increasing demand for vascular access devices. Additionally, the rising cancer cases and upsurging number of hospitals are contributing to the regional growth. For instance, in 2022, China recorded for 4,824,700 new cancer cases and 2,574,200 cancer-related deaths highlighting the need for intravenous treatments. Furthermore, as per CEIC data, number of hospitals in China increased to 38,4000 in 2023 up from 36,976 in 2022. Thus, increasing the demand for vascular access device continues to grow. Furthermore, India accounts for second largest share in Asia Pacific vascular access device market, owing to increasing healthcare expenditure. MarketsandMarkets

  • New Haven joins legal battle against funding cuts

    New Haven joins legal battle against funding cuts

    Last Thursday, New Haven joined 44 other cities and local officials in filing a legal brief against recent federal cuts to research funding.

    The cities filed an amicus brief in support of lawsuits filed by 22 states and associations of medical schools, hospitals and universities against recent cuts to federal research funding. On Feb. 7, the National Institutes of Health announced that scientific and medical institutions would be losing significant amounts of federal research funding.

    Like many of the other cities included in the brief, New Haven is home to universities and hospitals that employ thousands of researchers whose work and jobs depend on federal dollars. The brief explained how these cuts would negatively affect cities across the country.

    “New Haven is one the nation’s leading hubs for medical and scientific research. From bioscience to life science to quantum, these industries represent thousands of local jobs and millions of dollars to our local economy,” Mayor Justin Elicker said in a press release. “But, more importantly, this funding is supporting cutting-edge, lifesaving work that is identifying new medical treatments, curing chronic diseases, and advancing scientific discoveries that improve the everyday lives and wellbeing of our residents.”

    The NIH’s Feb. 7 decision caps reimbursements for indirect costs, such as lab maintenance, equipment and administrative support, at 15 percent, a significant reduction from Yale’s previous reimbursement rate of 69.7 percent. This decision “would have severe and long-term impacts on our jurisdictions,” the amicus brief reads.

    In many of the cities that joined the amicus brief, the research institutions most likely to be harmed are “at the center of bigger biotech and science-based economic hubs,” meaning that the loss of funds could cause cities’ economic systems “to degrade.”

    Yale submitted “a declaration of support” for the brief explaining that research at Yale and other Connecticut institutions benefits patients in New Haven and across the state and generates jobs benefiting the local and state economy.

    The brief argues that the NIH’s decision to cut funding is “arbitrary and capricious,” explaining that the NIH failed to consider the “substantial reliance interests” of universities, hospitals and other recipients of indirect cost funding.

    The NIH’s cuts to reimbursement rates were temporarily blocked nationwide by a federal court after 22 states filed a lawsuit against the policy change.

    The mayors’ Thursday brief advocated that the temporary restraining order against the Trump administration “be extended in duration and given nationwide effect.” On Friday, Judge Angel Kelley of the U.S. District Court for the District of Massachusetts extended the order until she decides on a more permanent ruling.

    “We join with cities across the country — in red states, purple states and blue states — to stop this illegal action that will cause layoffs, lab closures and undermine scientific progress in American cities,” said Boston Mayor Michelle Wu — whose jurisdiction spearheaded the brief.

    The amicus brief was led by the City of Boston, Massachusetts; the City of Cleveland, Ohio; the Mayor of Gainesville, Florida; the Metropolitan Government of Nashville and Davidson County, Tennessee; and the Mayor of Salt Lake City, Utah. Yale Daily News

  • Indian electronics industry should look at increasing exports to $100B

    Indian electronics industry should look at increasing exports to $100B

    The Indian electronics and electrical industry should look at increasing exports to $100 billion over the next 5-7 years, Commerce and Industry Minister Piyush Goyal said.

    The export volume of electronic goods ranks second in the country against 167th in 2015. In January, the export volume of electronic goods was $3 billion.

    Look at increasing exports to ” $100 billion in the next 5-7 years”, he said at the 16th Edition of ELECRAMA, organised by the Indian Electrical And Electronics Manufacturer’s Association (IEEMA) here.

    The minister also said India’s electronic goods industry must work together towards more resilient supply chains, upgrade quality standards and provide high-quality goods and services to the world at competitive rates.

    He urged the participants to work together to bring competitive advantages to the manufacturing sector.

    The minister stressed that the industry has a responsibility to ensure that consumers are provided better deals.

    He urged the industry leaders and participants to shun protectionism and focus on balancing the interests of the industry, particularly the MSME sector.

    Protectionism beyond a point starts hurting the consumer, Goyal said, adding that balancing the interests of the MSME sector, along with the customers, should be the industry’s biggest priority. PTI

  • SC rejects plea to regulate Internet prices in India

    SC rejects plea to regulate Internet prices in India

    The Supreme Court refused to entertain a plea seeking regulation of Internet prices in the country.

    A bench of Chief Justice of India Sanjiv Khanna and Justice Sanjay Kumar dismissed the plea filed by one Rajat, saying consumers had multiple options for availing of Internet services.

    “It’s a free market. There are several options. BSNL and MTNL are also giving you Internet,” the bench observed.

    The petitioner alleged that the majority of the market share was controlled by Jio and Reliance.

    The bench then said,”If you are alleging cartelisation, then go to the Competition Commission of India.” The top court, however, clarified that if the petitioner wanted to take any recourse to appropriate statutory remedy, he was at liberty to do so. PTI

  • Maharashtra aims to become India’s AI capital

    Maharashtra aims to become India’s AI capital

    Maharashtra is positioning itself to become India’s artificial intelligence (AI) capital, building on its existing status as the country’s data center and fintech hub, Chief Minister Devendra Fadnavis said at Nasscom 2025.

    The state, which currently hosts 60 per cent of India’s data center capacity in and around Navi Mumbai, recently secured AI and data center investments worth $20 billion at Davos. “We have created a new data center park around Navi Mumbai. And a lot of investments around data center are coming,” Fadnavis said during a fireside chat with Srikanth Velamakanni, cofounder and group CEO of Fractal.

    To support the growing data center infrastructure, Maharashtra plans to increase its power generation capacity from the current 45 gigawatts to 75 gigawatts by 2030, with 52 per cent coming from renewable sources. “Initially, we want to give a mixed type of green and conventional power to the data center. But somehow, in future, we feel that all this power should be green power,” the Chief Minister explained.

    The state has established an AI mission and formed a committee of business leaders to develop a new AI policy. “The terms of reference is to make Maharashtra leader in AI,” Fadnavis stated. The government is already training 10,000 women in AI in partnership with Microsoft.

    Maharashtra is also emerging as India’s startup capital, with approximately 20,000 startups, leading in both absolute numbers and investment. About 35 per cent of these startups operate in the fintech space, reinforcing Mumbai’s position as the fintech hub.

    The state is actively developing Global Capability Centers (GCCs), with plans to create dedicated ecosystems in Mumbai, Pune, Nagpur, Sambhajnagar, and Nashik. “We are creating a GCC park in Navi Mumbai, which will host many GCCs. There are four or five which we are in active talks and mostly will close,” Fadnavis revealed.

    A new innovation city spanning 300 acres is being planned in Navi Mumbai. “We want to host everything and anything in terms of technology, innovation and AI in this city,” the Chief Minister said, adding that Tata Group Chairman N. Chandrasekaran is helping develop the framework.

    In agriculture, Maharashtra is implementing the AgriStack program for end-to-end digitization of farming cycles. “It is about digitization of the farmlands, farm produce, market access, every single thing,” Fadnavis explained. The state has also digitized multi-purpose societies in villages to enhance farmer financing and market connectivity.

    Looking ahead to the 2027 Nashik Kumbh, the state plans to leverage technology for crowd management and administration. “This will be technologically most advanced Kumbh… People, even those who just cannot go and bathe in the holy water will get the experience of having bathed in the holy water,” Fadnavis said, while emphasizing that the sanctity of the event will remain unchanged.

    The state’s broader economic vision includes becoming India’s first trillion-dollar subnational economy. The Mumbai Metropolitan Region alone has the potential to achieve a $1.5 trillion economy, according to a roadmap developed with NITI Aayog. “If we work properly, the MMR region itself can become a 1.5 trillion dollar economy,” Fadnavis stated. The Hindu BusinessLine